3D Systems Corporation (NYSE:DDD) will showcase its latest 3D content-to-print solutions at the American Institute of Architects’ 2012 National Convention and Design Exposition at the Walter E. Washington Convention Center in Washington, DC May 17-19th in booth number 2160.

*****************

Crown Equity Holdings Inc. (CRWE.OB)

CRWE AD-Services, a division of Crown Equity Holdings Inc. (CRWE) is a full service multimedia advertising company specializing in internet marketing. Their goal is to provide you with a customized advertising blue print using their expansive resources.

CRWE Ad Services provides modern and unique advertising campaigns. They are dedicated to offering the most cost effective advertising solutions.

Among the best growth areas in advertising in recent years have been advertising on mobile devices, which is still in its infancy, advertising on movie screens and advertising online. Analysts at Gartner expect mobile advertising to reach $13 billion worldwide by 2013. Magna forecasts that global online advertising will grow to $71 billion in 2011.

Crown Equity Holdings Inc. offers advertising branding and marketing services as a worldwide online multi-media publisher with its digital network of websites and focuses on the distribution of information for the purpose of bringing together a targeted audience and the advertisers that want to reach them. CRWE advertising services cover and connect a range of marketing specialties, as well as provide search engine optimization for clients interested in online media awareness.

For more information about CRWE AD-Services please visit http://crwe-adservices.com

For more information about Crown Equity Holdings Inc. please visit http://www.crownequityholdings.com

*****************

Nymox Pharmaceutical Corporation (Nasdaq:NYMX) reported a symposium and panel discussion on NX-1207, the Company’s Phase 3 drug for benign prostatic hyperplasia (BPH), to be held during the 2012 Annual Meeting of the American Urological Association in Atlanta, GA 3:00 p.m. May 20.

The Symposium will be held in the Georgia World Congress Center. The symposium, “Clinical studies of NX-1207: Phase 3 Injectable for BPH,” will be chaired by Ronald Tutrone Jr, MD, FACS of Towson, MD, who will present an overview of NX-1207 and the NX-1207 clinical trials to date, including the three Phase 3 clinical trials currently in progress. Barton H. Wachs, MD, FACS, of Long Beach, CA, will present data from the new studies of the long-term efficacy of NX-1207 treatment. Mohamed Bidair, MD, FACS(C) of San Diego, CA, and Nicholas Franco, MD, FACS of Naples, FL will participate in the panel discussion in the symposium, along with Dr. Tutrone and Dr. Wachs.

*****************

Cardtronics, Inc. (Nasdaq:CATM), the world’s largest retail ATM owner, announced today that its chief financial officer, Chris Brewster, will be presenting on behalf of the company at the 40th Annual J.P. Morgan Global Technology, Media and Telecom Conference in Boston on May 17 at 10:30 a.m. EDT.

Sign Up for Free Stock Newsletter at http://www.pennyotcstock.com/signup

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. PennyOtcStock.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold PennyOmega.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://pennyotcstock.com/disclaimer) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a media-advertisement and newswire company. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.

Crown Equity Holdings Inc. (CRWE.OB)

Crown Tele Services Inc. is a provider of affordable, world class (VoIP) communications solutions and is a subsidiary of Crown Equity Holdings Inc. (CRWE)

Crown Tele Services is a leading provider of communications services. Their network utilizes blazing fast fiber optic channels throughout the world with our engineers devoted to guaranteeing the highest quality and reliability possible.

Crown Tele Services goal is to provide the client affordable, world class communication solutions without giving up popular features like call waiting, call forwarding, toll free, voice mail and more.

Crown Tele Services mission is to create lifelong relationships through customer satisfaction, by offering communications solutions designed to fit your business needs while saving you a ton of money. Crown Tele Services is able to offer features to the small business owner previously only available to large enterprise corporations.

Crown Equity Holdings Inc. offers advertising branding and marketing services as a worldwide online multi-media publisher with its digital network of websites and focuses on the distribution of information for the purpose of bringing together a targeted audience and the advertisers that want to reach them. CRWE advertising services cover and connect a range of marketing specialties, as well as provide search engine optimization for clients interested in online media awareness.

For more information about Crown Tele Services Inc. please visit http://crownteleservices.com

For more information about Crown Equity Holdings Inc. please visit http://www.crownequityholdings.com

*****************

QuinStreet, Inc. (Nasdaq:QNST), the leader in vertical marketing and media online, reported that Greg O’Brien has joined the company as senior vice president of business development.

Greg brings extensive industry experience and contacts to QuinStreet. He most recently served as chief executive officer of The CollegeBound Network, a provider of online marketing services to the Education industry. Greg also worked previously as chief financial officer of CollegeBound and as an investment banker to media and technology clients.

*****************

BG Medicine, Inc. (Nasdaq:BGMD), a company focused on the development and commercialization of novel cardiovascular diagnostics, reported that it has filed a 510(k) Premarket Notification with the U.S. Food and Drug Administration (FDA) for regulatory clearance of an expanded indication for its BGM Galectin-3 test.

The blood test was cleared by the FDA in November 2010 and is currently indicated for use in patients with chronic heart failure who are at increased risk for hospitalizations or death based on elevated levels of galectin-3. Subject to FDA clearance, the new application would expand the indicated use to the general adult population to identify those with an elevated level of galectin-3, which is associated with an increased risk for new-onset heart failure.

*****************

Pluristem Therapeutics, Inc. (Nasdaq:PSTI) reported that cardiac function in a diabetic-induced diastolic dysfunction in animals improved following PLacental eXpanded (PLX cells) administration.

The study was conducted as part of the European Commission’s Seventh Framework Program (FP7) in collaboration with Professor Doctor Carsten Tschope and his staff at the Charite Universitaetsmedizin Berlin, Berlin-Bradenburg Center for Regenerative Therapies (BCRT), Berlin, Germany. Dr. Tschope is also a member of the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology.

Sign Up for Free Stock Newsletter at http://www.pennyotcstock.com/signup

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. PennyOtcStock.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold PennyOmega.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://pennyotcstock.com/disclaimer) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a media-advertisement and newswire company. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.

Highlights how Codexis platform enables breakthrough biocatalytic processes

REDWOOD CITY, Calif.–(CRWENewswire)–Codexis, Inc. (Nasdaq:CDXS), a developer of cost-advantaged processes for the production of biofuels, bio-based chemicals, and pharmaceutical intermediates, today announced that the United States Patent and Trademark Office (USPTO) has granted Codexis’ patent covering the biocatalysts and biocatalytic processes used to make key pharmaceutical intermediates in the synthesis of leading hepatitis-C therapeutics.

The patent is titled “BIOCATALYTIC PROCESSES FOR THE PREPARATION OF SUBSTANTIALLY STEREOMERICALLY PURE FUSED BICYCLIC PROLINE COMPOUNDS” and was issued as U.S. patent number 8,178,333. The 20-year term of this patent does not expire until 2029.

“The patent is another example of how the Codexis CodeEvolver™ platform is enabling breakthrough biocatalytic processes to produce pharmaceutical intermediates, in this case for the latest hepatitis-C therapeutics,” said Peter Seufer-Wasserthal, Senior Vice President, Codexis Pharmaceuticals. “This patent specifically provides exclusivity for the use of our novel biocatalysts and production processes in the manufacture of these key intermediates. The ability to provide custom and high-performance manufacturing processes for our pharmaceuticals customers creates a competitive advantage for Codexis. ”

This patent follows a recently published article in the Journal of the American Chemical Society (JACS) that discusses collaborative research conducted by Merck and Codexis scientists to develop a highly efficient, enzyme-based production method for a key intermediate in the production of boceprevir.

To view the publication, please go to: http://pubs.acs.org/doi/pdf/10.1021/ja3010495

About Codexis, Inc.

Codexis, Inc. is a developer of cost-advantaged processes for the production of biofuels, bio-based chemicals, and pharmaceutical intermediates. Codexis’ product lines include CodeXyme™ Cellulase Enzymes and CodeXol™ Detergent Alcohol. Partners and customers include global leaders such as Shell, Merck and Pfizer. For more information, see www.codexis.com.

Contact:

Codexis, Inc.
Investors: 212-362-1200
ir@codexis.com
Kelly McAlearney, 415-503-4073 (Media)
media@codexis.com

Source: Codexis, Inc.

********************************************************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWENewswire.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWENewswire.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://crwenewswire.com/disclaimer). Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a media-advertisement and newswire company. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.

NEW YORK, May 15, 2012 (CRWENewswire)– Capital Trust, Inc. (NYSE:CT) (the “Company”) announced today that its Board of Directors (the “Board”) has formed a Special Committee of the Board comprised of independent directors (the “Special Committee”) to consider and explore strategic alternatives available to the Company in order to maximize shareholder value. The Special Committee intends to undertake a thorough exploration of the full range of alternatives, including a possible sale of the Company and has retained Evercore Partners to serve as its financial advisor.

No decision has been made to engage in a transaction or transactions resulting from the Special Committee’s exploration of strategic alternatives. There can be no assurance that that the Special Committee or the Board will authorize the pursuit of any strategic alternative. Moreover, there can be no assurance with respect to the terms or the timing of any transaction, or whether a transaction will ultimately result at all.

As a matter of policy, the Company does not comment on or provide the market with updates as to the status of any informal expressions of interest or formal proposals or offers presented to the Company from time to time, or the course of discussions with any prospective counterparties, nor will it comment upon any rumors with regard to either of the foregoing or make a further announcement regarding the Special Committee’s consideration of any proposal or other expressions of interest until such time, if ever, that it enters into a definitive agreement for a completed transaction or is otherwise required to make an announcement.

Forward-Looking Statements

This news release contains certain forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, including statements relating to future financial results and business prospects. The forward-looking statements contained in this news release are subject to certain risks and uncertainties including, but not limited to, the performance of the Company’s investments, the timing of collections, its capability to repay indebtedness as it comes due, competition for servicing and investment management assignments, its ability to originate investments, the availability of capital and the Company’s tax status, as well as other risks indicated from time to time in the Company’s Form 10-K and Form 10-Q filings with the Securities and Exchange Commission. The Company assumes no obligation to update or supplement forward-looking statements that become untrue because of subsequent events or circumstances.

About Capital Trust

Capital Trust, Inc. is a fully integrated, self-managed real estate finance and investment management company that specializes in credit sensitive structured financial products. To date, the Company’s investment programs have focused primarily on loans and securities backed by commercial real estate assets, investing both for its balance sheet and for third party vehicles. Capital Trust is a real estate investment trust traded on the New York Stock Exchange under the symbol “CT.” The Company is headquartered in New York City.

Source: Capital Trust, Inc.

********************************************************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWENewswire.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWENewswire.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://crwenewswire.com/disclaimer). Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a media-advertisement and newswire company. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.

Aerojet, a GenCorp (NYSE:GY) company and its strategic alliance partner Teledyne Brown Engineering, Inc., a subsidiary of Teledyne Technologies Incorporated (NYSE:TDY), reported that the companies hosted Alabama Governor Robert Bentley, along with Congressman Mo Brooks and several other dignitaries at Teledyne Brown’s headquarters in Huntsville, Ala.

The event demonstrated the technical and program progress the partners have made since the alliance was created a year ago as well as highlighted the unveiling of an Aerojet AJ26 liquid rocket engine at its new home at Teledyne Brown.

The AJ26 is just one of many potential development and production programs under the Aerojet-Teledyne Brown strategic alliance that could lead to significant engineering and manufacturing work in Huntsville.

*****************

National Research Corporation (NASDAQ:NRCI) reported that its Board of Directors has declared a regular quarterly cash dividend of $0.26 (twenty-six cents) per share payable June 29, 2012, to shareholders of record as of the close of business on Friday, June 1, 2012.

*****************

Crown Equity Holdings Inc. (CRWE.OB)

Crown Equity Holdings Inc. (CRWE) recently launched a new online service company CRWE Direct.

CRWE Direct is an online business-to-business marketplace for manufacturers and small to large businesses to purchase various types of merchandise. Manufacturers may start downloading their product immediately, free of charge during the next six months. Thereafter, there will be various annual fees. The listing process and image loading for both sites are user-friendly.

The 2010 U.S. Census data shows estimates for B2B revenues transacted online at approximately US $300 billion.

Crown Equity Holdings Inc. offers advertising branding and marketing services as a worldwide online multi-media publisher with its digital network of websites and focuses on the distribution of information for the purpose of bringing together a targeted audience and the advertisers that want to reach them. CRWE advertising services cover and connect a range of marketing specialties, as well as provide search engine optimization for clients interested in online media awareness.

For more information about CRWE Direct please visit http://www.crwedirect.com

For more information about Crown Equity Holdings Inc. please visit http://www.crownequityholdings.com

Sign Up for Free Stock Newsletter at http://www.pennyotcstock.com/signup

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. PennyOtcStock.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold PennyOmega.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://pennyotcstock.com/disclaimer) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a media-advertisement and newswire company. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.